QQQM invests in US large-cap companies, tracking its benchmark, the NASDAQ-100 index. See why I rate the fund a hold.

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

The company's robust balance sheet and growth prospects are noted, but not enough to justify a market-beating performance.

Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4 ...

With regards to style, growth remains the dominant style in the market with large cap growth stocks outperforming large cap ...

A warning of a U.S. stock market bubble, advises diversification into value stocks, commodities, and international equities ...

With that in mind, the ROCE of Powell Industries (NASDAQ ... In the above chart we have measured Powell Industries' prior ROCE against its prior performance, but the future is arguably more ...

So when we looked at RADCOM (NASDAQ:RDCM ... In the above chart we have measured RADCOM's prior ROCE against its prior performance, but the future is arguably more important.

Triumph Financial's unique factoring unit for trucking fleets faces challenges with stock performance and profitability, ...

So when we looked at the ROCE trend of Autodesk (NASDAQ ... In the above chart we have measured Autodesk's prior ROCE against its prior performance, but the future is arguably more important.

Lam Research's Q2-2025 earnings beat expectations, with strong revenue and EPS growth. Read why I remain neutral on LRCX ...

Q4 2024 Earnings Call Transcript January 29, 2025 Navient Corporation misses on earnings expectations. Reported EPS is $0.25 ...